BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 33550243)

  • 1. Protocol for assessing whether cognition of preterm infants <29 weeks' gestation can be improved by an intervention with the omega-3 long-chain polyunsaturated fatty acid docosahexaenoic acid (DHA): a follow-up of a randomised controlled trial.
    Gould JF; Makrides M; Sullivan TR; Anderson PJ; Gibson RA; Best KP; McPhee AJ; Doyle LW; Opie G; Travadi J; Cheong J; Davis PG; Sharp M; Simmer K; Collins CT
    BMJ Open; 2021 Feb; 11(2):e041597. PubMed ID: 33550243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protocol for assessing if behavioural functioning of infants born <29 weeks' gestation is improved by omega-3 long-chain polyunsaturated fatty acids: follow-up of a randomised controlled trial.
    Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Best KP; Collins CT
    BMJ Open; 2021 May; 11(5):e044740. PubMed ID: 33952546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing whether early attention of very preterm infants can be improved by an omega-3 long-chain polyunsaturated fatty acid intervention: a follow-up of a randomised controlled trial.
    Gould JF; Colombo J; Collins CT; Makrides M; Hewawasam E; Smithers LG
    BMJ Open; 2018 May; 8(5):e020043. PubMed ID: 29804059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.
    Collins CT; Gibson RA; Makrides M; McPhee AJ; Sullivan TR; Davis PG; Thio M; Simmer K; Rajadurai VS;
    BMC Pediatr; 2016 Jun; 16():72. PubMed ID: 27250120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of maternal docosahexaenoic acid supplementation on brain development and neurodevelopmental outcomes of breastfed preterm neonates: protocol for a follow-up at preschool age of a randomised clinical trial (MOBYDIckPS).
    Guillot M; Robitaille CA; Turner L; Pronovost E; Caouette G; Matte-Gagné C; Olivier F; Bartholomew J; Massé É; Morin A; Mohamed I; Marc I
    BMJ Open; 2022 May; 12(5):e057482. PubMed ID: 35508343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neonatal Docosahexaenoic Acid in Preterm Infants and Intelligence at 5 Years.
    Gould JF; Makrides M; Gibson RA; Sullivan TR; McPhee AJ; Anderson PJ; Best KP; Sharp M; Cheong JLY; Opie GF; Travadi J; Bednarz JM; Davis PG; Simmer K; Doyle LW; Collins CT
    N Engl J Med; 2022 Oct; 387(17):1579-1588. PubMed ID: 36300974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does n-3 LCPUFA supplementation during pregnancy increase the IQ of children at school age? Follow-up of a randomised controlled trial.
    Gould JF; Treyvaud K; Yelland LN; Anderson PJ; Smithers LG; Gibson RA; McPhee AJ; Makrides M
    BMJ Open; 2016 May; 6(5):e011465. PubMed ID: 27188814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-Dose Docosahexaenoic Acid in Newborns Born at Less Than 29 Weeks' Gestation and Behavior at Age 5 Years: Follow-Up of a Randomized Clinical Trial.
    Gould JF; Roberts RM; Anderson PJ; Makrides M; Sullivan TR; Gibson RA; McPhee AJ; Doyle LW; Bednarz JM; Best KP; Opie G; Travadi J; Cheong JLY; Davis PG; Sharp M; Simmer K; Tan K; Morris S; Lui K; Bolisetty S; Liley H; Stack J; Collins CT
    JAMA Pediatr; 2024 Jan; 178(1):45-54. PubMed ID: 37983037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis.
    Marc I; Lavoie PM; McPhee AJ; Collins CT; Simonyan D; Pronovost E; Guillot M; Gould JF; Mohamed I; Beltempo M; Boutin A; Fortier I; Sullivan TR; Moore L; Makrides M
    BMJ Open; 2023 Jul; 13(7):e076223. PubMed ID: 37518076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediation Analysis to Untangle Opposing Associations of High-Dose Docosahexaenoic Acid With IQ and Bronchopulmonary Dysplasia in Children Born Preterm.
    Sullivan TR; Gould JF; Bednarz JM; McPhee AJ; Gibson R; Anderson PJ; Best KP; Sharp M; Cheong JLY; Opie GF; Travadi J; Davis PG; Simmer K; Collins CT; Doyle LW; Makrides M
    JAMA Netw Open; 2023 Jun; 6(6):e2317870. PubMed ID: 37294565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurodevelopmental outcomes at 7 years' corrected age in preterm infants who were fed high-dose docosahexaenoic acid to term equivalent: a follow-up of a randomised controlled trial.
    Collins CT; Gibson RA; Anderson PJ; McPhee AJ; Sullivan TR; Gould JF; Ryan P; Doyle LW; Davis PG; McMichael JE; French NP; Colditz PB; Simmer K; Morris SA; Makrides M
    BMJ Open; 2015 Mar; 5(3):e007314. PubMed ID: 25787990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High doses of enteral docosahexaenoic acid omega-3 supplementation for prevention of bronchopulmonary dysplasia in very preterm infants: a protocol for a systematic review and meta-analysis.
    Marc I; Boutin A; Pronovost E; Guillot M; Bergeron F; Moore L; Makrides M
    BMJ Open; 2022 Oct; 12(10):e064515. PubMed ID: 36253040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subgroup analyses of a randomized trial of DHA supplementation for infants born preterm with assessments of cognitive development up to 7-years of age: What happens in infants born <29 weeks' gestation?
    Gould JF; Bednarz JM; Sullivan TR; McPhee AJ; Gibson RA; Makrides M
    Prostaglandins Leukot Essent Fatty Acids; 2023 Dec; 198-199():102593. PubMed ID: 37979339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DHA supplementation in infants born preterm and the effect on attention at 18 months' corrected age: follow-up of a subset of the N3RO randomised controlled trial.
    Hewawasam E; Collins CT; Muhlhausler BS; Yelland LN; Smithers LG; Colombo J; Makrides M; McPhee AJ; Gould JF
    Br J Nutr; 2021 Feb; 125(4):420-431. PubMed ID: 32660658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.
    Auestad N; Scott DT; Janowsky JS; Jacobsen C; Carroll RE; Montalto MB; Halter R; Qiu W; Jacobs JR; Connor WE; Connor SL; Taylor JA; Neuringer M; Fitzgerald KM; Hall RT
    Pediatrics; 2003 Sep; 112(3 Pt 1):e177-83. PubMed ID: 12949309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Docosahexaenoic Acid (DHA) Supplementation of Preterm Infants on Growth, Body Composition, and Blood Pressure at 7-Years Corrected Age: Follow-Up of a Randomized Controlled Trial.
    Best KP; Sullivan TR; Gunaratne AW; Gould JF; Gibson RA; Collins CT; Makrides M; Green TJ
    Nutrients; 2023 Jan; 15(2):. PubMed ID: 36678206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysis.
    Marc I; Boutin A; Pronovost E; Perez Herrera NM; Guillot M; Bergeron F; Moore L; Sullivan TR; Lavoie PM; Makrides M
    JAMA Netw Open; 2023 Mar; 6(3):e233934. PubMed ID: 36943265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Docosahexaenoic acid supplementation of preterm infants and parent-reported symptoms of allergic disease at 7 years corrected age: follow-up of a randomized controlled trial.
    Gunaratne AW; Makrides M; Collins CT; Gibson RA; McPhee AJ; Sullivan TR; Gould JF; Green TJ; Doyle LW; Davis PG; French NP; Colditz PB; Simmer K; Morris SA; Best KP
    Am J Clin Nutr; 2019 Jun; 109(6):1600-1610. PubMed ID: 31070712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Docosahexaenoic Acid Supplementation vs Placebo on Developmental Outcomes of Toddlers Born Preterm: A Randomized Clinical Trial.
    Keim SA; Boone KM; Klebanoff MA; Turner AN; Rausch J; Nelin MA; Rogers LK; Yeates KO; Nelin L; Sheppard KW
    JAMA Pediatr; 2018 Dec; 172(12):1126-1134. PubMed ID: 30357263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study protocol for a randomised controlled trial evaluating the effect of prenatal omega-3 LCPUFA supplementation to reduce the incidence of preterm birth: the ORIP trial.
    Zhou SJ; Best K; Gibson R; McPhee A; Yelland L; Quinlivan J; Makrides M
    BMJ Open; 2017 Sep; 7(9):e018360. PubMed ID: 28947468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.